What is neutropenia? What causes neutropenia?
8/28/2013
Neutropenia is a blood condition, a granulocyte disorder, that characterized by a deficiency of neutrophils, a type of white blood cell that defends the body against bacterial and fungal infections. Granulocytes are a category of white blood cells. They are made in bone marrow...
Serascience Limited, a specialist cancer diagnostics company established by a joint venture between Abingdon Health and the University of Birmingham, announces the receipt of European CE Mark approval for the commercial sale of Seralite®, its proprietary point-of-care diagnostic device for multiple myeloma...
Therapeutic algorithm developed for optimal nosebleed management
8/28/2013
Approximately 60 percent of people experience epistaxis, commonly known as nosebleed, at least once in their lifetime. Of those who experience nosebleed, six percent require medical treatment. A study in the September 2013 issue of Otolaryngology-Head and Neck Surgery, explores which nosebleed treatment options demonstrate the best outcomes...
New minimally invasive technique for treating melanoma
8/28/2013
At first, Krista Easom figured the little red bump on her foot was nothing more than a blister. It didn't hurt, but after a couple months, it didn't go away either. She booked an appointment with a dermatologist to have it removed. She wasn't worried...
High coffee intake may help against prostate cancer
8/28/2013
Consuming four or more cups of coffee a day could reduce the risk of prostate cancer recurrence and disease progression, according to a study published in the journal Cancer Causes and Control. Researchers from the Fred Hutchinson Cancer Research Center in Seattle analyzed 1,001 prostate cancer survivors from a population-based study, aged between 35 and 74 years of age...
Tumor growth reduced, cancer cells crippled by disabling ether lipid generating enzyme
8/28/2013
Knocking out a single enzyme dramatically cripples the ability of aggressive cancer cells to spread and grow tumors, offering a promising new target in the development of cancer treatments, according to a new study by researchers at the University of California, Berkeley...
Providing extra oxygen to oxygen-deprived muscle following injury
8/28/2013
The same compound in a common household clothes detergent shows promise as a treatment to preserve muscle tissue after severe injury. Researchers at the Wake Forest Baptist Medical Center's Institute for Regenerative Medicine hope the oxygen-generating compound could one day aid in saving and repairing limbs and tissue...
Stress fuels cancer spread by triggering master gene
8/27/2013
A new study from the US published in the Journal of Clinical Investigation finds that activation of a master gene called ATF3 that is important for helping cells adapt to stress may be involved in helping breast, and possibly other cancers spread to other parts of the body (metastasis)...
Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas MD Anderson Cancer Center...
Genomic differences discovered in types of cervical cancer
8/27/2013
A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type's molecular idiosyncrasies...